Study: Biologic therapy did not reduce IBD-related hospitalizations and surgeries

[Ketua Dobbs]

Study: Biologic therapy did not reduce IBD-related hospitalizations and surgeries

The introduction of infliximab, the first biologic therapy approved for the treatment of inflammatory bowel diseases, did not result in lower rates of hospitalizations or intestinal surgeries among patients living with IBD in Ontario, according to a study published by authors from several Canadian hospitals and ICES in the journal Gut.
Source: Study: Biologic therapy did not reduce IBD-related hospitalizations and surgeries